Your browser doesn't support javascript.
loading
EPIK-O/ENGOT-OV61: alpelisib plus olaparib vs cytotoxic chemotherapy in high-grade serous ovarian cancer (phase III study).
Konstantinopoulos, Panagiotis A; Gonzalez-Martin, Antonio; Cruz, Felipe Melo; Friedlander, Michael; Glasspool, Rosalind; Lorusso, Domenica; Marth, Christian; Monk, Bradley J; Kim, Jae-Weon; Hinson, Patsy; Ajipa, Olga; Pretre, Vincent; Han, Yu; Matulonis, Ursula A.
Afiliação
  • Konstantinopoulos PA; Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Gonzalez-Martin A; Clínica Universidad de Navarra & Program in Solid Tumors, Center for Applied Medical Research (CIMA), Pamplona, 31008, Spain.
  • Cruz FM; Núcleo de Pesquisa e Ensino da Rede São Camilo, São Paulo, 04014-002, Brazil.
  • Friedlander M; Department of Medical Oncology, Prince of Wales Hospital & Prince of Wales Clinical School, University of New South Wales, Sydney, 2031, Australia.
  • Glasspool R; Beatson West of Scotland Cancer Centre & University of Glasgow, Glasgow, G12, UK.
  • Lorusso D; Fondazione Policlinico Universitario A Gemelli IRCCS & Catholic University of Sacred Heart, Rome, 00168, Italy.
  • Marth C; Medizinische Universität Innsbruck, Innsbruck, 6020, Austria.
  • Monk BJ; HonorHealth Research Institute, University of Arizona, Creighton University, Phoenix, AZ 85012, USA.
  • Kim JW; Seoul National University, Seoul, 08826, South Korea.
  • Hinson P; Ovarian Cancer Research Alliance (OCRA), New York, NY 10122, USA.
  • Ajipa O; Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA.
  • Pretre V; Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA.
  • Han Y; Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA.
  • Matulonis UA; Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Future Oncol ; 18(31): 3481-3492, 2022 Oct.
Article em En | MEDLINE | ID: mdl-36066851

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Revista: Future Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Revista: Future Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos